SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Andus T, Bauer J, Gcrok W. Effect of cytokines on the liver. Hepatology 1991; 13: 36475.
  • 2
    Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 162752.
  • 3
    Anastassakos C, Alexander GJM, Wolstcncroft RA, Avery JA, Portmann BC, Panayi GS, Dumonde DC, Eddleston ALWF, Williams R. Interlcukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1988; 94: 9991005.
  • 4
    Yoshioka K, Kakumu S, Arao M, Tstusumi Y, Inoue M. Tumor necrosis factor-α production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989; 10: 76973.
  • 5
    Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJM, Williams R. Increased production of tumor necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991; 12: 2415.
  • 6
    Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ito Y, Takayanagi M, Ida N. Serum interleukin-6 levels in patients with chronic hepatitis B. Am J Gastroenterol 1991; 86: 18048.
  • 7
    Dudley FJ, Fox RA, Sherlock S. Cellular immunity and hepatitisassociated, australia antigen liver disease. Lancet 1972; i: 7236.
  • 8
    Bernuau J, Benhamou JP. Fulminant and subfulminant liver failure. In: MclntyreN, BenhamouJP, BircherJ, RizzettoM, RodesJ, eds. Oxford textbook of clinical hepatology. vol. 2. Oxford : Oxford University Press, 1991;90342.
  • 9
    Muto Y, Nouri-Aria KT, Meager A, Alexander GJM, Eddleston ALWF, Williams R. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure Lancet 1988; ii: 724.
  • 10
    Van Damme J, Ley MD, Opdenakker G, Billiau A, Somer PD. Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interlcukin-1. Nature 1985; 314: 2668.
  • 11
    Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Möller A, Jacobsen H, Kirchner H. Antiviral effects of recombinant tumor necrosis factor in vitro. Nature 1986; 323: 8169.
  • 12
    Kohase M, DeStefano DH, May LT, Vilček J, Sehgal PB. Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 65966.
  • 13
    Darlington GJ, Wilson DR, Lachman LB. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biology 1986; 103: 78793.
  • 14
    Heinrich PC, Castell JV, Andus T. Interleukin-6 and acute phase response. Biochem J 1990; 265: 62136.
  • 15
    Nakamura T, Arakaki R, Ichihara A. Interleukin-1β is a potent growth inhibitor of adult rat hepatocytes in primary culture. Exp Cell Res 1988; 179: 48897.
  • 16
    Huggett AC, Fiord CP, Thorgeirsson SS. Effects of interleukin-6 on the growth of normal and transformed rat liver cells in culture. Growth Factors 1989; 2: 839.
  • 17
    Warren RS, Starnes Jr HF, Aleock N, Galvano S, Brennan MF. Hormonal and metabolic response to recombinant human tumor necrosis factor in rat: in vitro and in vivo. Am J Physiol 1988; 255: E20612.
  • 18
    Feingold KR, Soued M, Grunfeld C. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats. Biochem Biophys Res Commun 1988; 153: 57682.
  • 19
    Kuma S, Inaba M, Ogata H, Inaba K, Okumura T, Saito K, Yamamoto M, Ikehara S. Effect of human recombinant inlerleukin-6 on the proliferation of mouse hepatocytes in the primary culture. Immunobiol 1990; 180: 23542.
  • 20
    Arend WP, Joslin FG, Thompson RC, Hannum CH. An IL-l inhibitor from human monocytes: production and characterization of biologic properties. J Immunol 1989; 143: 18518.
  • 21
    Mclntyre KW, Stepan GJ, Kolinsky KD, Benjamm WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL. Inhibition of interleukin-1 (IL-11 binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti IL-1 receptor monoclonal antibody. J Exp Med 1991; 173: 9319.
  • 22
    Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1-receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 40410.
  • 23
    Trey C, Davidson CS. The management of fulminant hepatic failure. In: PopperH, SchffnerF, eds. Progress in liver disease. New York : Grune and Stratton, 1970; 28298.
  • 24
    Yoshiba M, Sekiyama K, Iwamura Y, Sagata F. Development of reliable artificial liver support (ALS)-plasma exchange in combination with hemodiafiltration using high-performance membranes. Dig Dis Sci 1993; 38: 46976.
  • 25
    Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′- noncoding region. Japan J Exp Med 1990; 60: 21522.
  • 26
    Tsubouchi H, Nitani Y, Hirono S, Nakayama H, Gohda E, Arkaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13: 15.
  • 27
    Rakela J, Lange SM, Ludwig J, Baldus WP. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985; 60: 28992.
  • 28
    Nakayama H, Tsubouchi H, Gohda E, Koura M, Nagahama J, Yoshida H, Daikuhara Y, Hashimoto S. Stimulation of DNA synthesis in adult rat hepatocytes in primary culture by sera from patients with fulminant hepatic failure. Bio Res 1985; 6: 2317.
  • 29
    Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis; a study of proliferating cell nuclear antigen expression. Hepatology 1992; 15: 70713.
  • 30
    Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S, Daikuhara Y. Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 1986; 166: 13950.
  • 31
    Strain AJ, Ismail T, Tsubouchi H, Arakaki N, Hishida T, Kitamura N, Daikuhara Y, McMaster P. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest 1991; 87: 18537.
  • 32
    Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16: 122735.
  • 33
    Akerman P, Cote P, Yang SQ, McClain C, Nelson S, Bagby GJ, Diehl AM. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 1992; 263: G57985.
  • 34
    Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinarello CA. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology 1993; 18: 11328.
  • 35
    Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA. Production of interleukin-1 receptor antagonist during experimental endotoxaemia. Lancet 1991; 338: 14234.
  • 36
    Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991; 5: 33843.
  • 37
    Fischer B, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge L, Kenney JS, Remick DG, Bloedow DC, Thompson RC, Lowry SF, Moldawer LL. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but Tails to alter host responses to sublethal endotoxemia. J Clin Invest 1992; 89: 15517.
  • 38
    Fischer E, Van Zee KJ, Marano A, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992; 79: 2196200.
  • 39
    Dinarello CA, Wolf SM. The role of interleukin-1 in disease. New Engl J Med 1993; 328: 10613.
  • 40
    Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties or recombinant human monocyte-derived interleukin 1- receptor antagonist. J Clin Invest 1990; 85: 16947.